Cornelis van Tilburg

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Cornelis van Tilburg

Feb 2, 2025, 02:01 | Science

Shushan Hovsepyan: Elective discontinuation of Larotrectinib in Pediatric TRK Fusion Sarcomas by Leo Mascarenhas

Shushan Hovsepyan, Editor-in-Chief of OncoDaily Medical Journal, shared a post on LinkedIn about a recent…

Oct 29, 2024, 10:18 | Blog

Findings on the treatment of thyroid cancer and neuroblastoma in pediatric and adolescent patients - Hopp-Kindertumorzentrum Heidelberg

Hopp-Kindertumorzentrum Heidelberg shared a post on X: "Greetings from Honululu at Hopp-Kindertumorzentrum Heidelberg, DKFZ and…

Mar 27, 2024, 23:42 | Blog

Speakers for the next open ALADDIN webinar are confirmed! - ALADDIN Education

ALADDIN Education posted on LinkedIn: “Speakers for the next open ALADDIN webinar are confirmed! Dominik Karres…

All: 3 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023